Report Code : CVMI2603252601416 | Published Date : March 30, 2025

1 | Market Overview

The global central nervous system (CNS) biomarker market is growing quickly, driven by the increasing need for early diagnosis, targeted treatments, and effective disease monitoring of neurological disorders such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy. CNS biomarkers are essential in drug development, clinical trials, and diagnostics, providing insights into disease progression, treatment response, and prognosis.

Advancements in imaging technologies, genomics, proteomics, and fluid-based biomarker discovery drive market growth. The growing burden of neurodegenerative diseases, along with increased investment in precision medicine and neuroscience research, further accelerates demand.

2 | Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

4.92

Historical benchmark

2024

7.93

Five-year CAGR 10.1%

2031

17.89

Seven-year CAGR 12.3%

The market is expected to more than double by 2031, fueled by demand for early diagnostics, precision neurology, and biomarker-driven clinical trials.

 

3 | Key Market Drivers

  • Rising Prevalence of Neurological Disorders: Increasing rates of Alzheimer's, Parkinson's, and multiple sclerosis.
  • Demand for Early Diagnosis and Disease Monitoring.
  • Growth in Precision Medicine and Targeted Therapies.
  • Advancements in Omics Technologies and Imaging Biomarkers.
  • Increasing CNS Drug Development and Clinical Trials.

 

4 | Market Challenges

  • High Cost of Biomarker Discovery and Validation.
  • Complexity in CNS Disease Heterogeneity.
  • Regulatory Hurdles for Clinical Biomarker Adoption.
  • Limited Standardization in Biomarker Validation Across Regions.

 

5 | Competitive Landscape

The CNS biomarker market is somewhat consolidated, with leading companies concentrating on biomarker assays, imaging diagnostics, and neurodegenerative disease research.

Market Share Estimates (2024):

Company

Estimated Market Share

Key Offerings

Thermo Fisher Scientific

20%

Immunoassays, proteomics tools, genomics biomarkers

Bio-Rad Laboratories

17%

Multiplex assays, neurodegeneration biomarker kits

Merck KGaA (MilliporeSigma)

15%

Neurology ELISAs, proteomics reagents

PerkinElmer Inc.

12%

Imaging biomarkers, CNS assay solutions

Others (QIAGEN, Abcam, Roche Diagnostics, regional OEMs)

36%

Specialized assays, imaging, and omics-based biomarkers

 

6 | Market Segmentation
By Biomarker Type:

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Prognostic Biomarkers
  • Diagnostic Biomarkers

 

By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Disease Risk Assessment
  • Personalized Medicine
  • Clinical Trials Monitoring

 

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Labs
  • Contract Research Organizations (CROs)

 

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

 

7 | Strategic Outlook

Future growth in the CNS biomarker market will be driven by AI-powered biomarker discovery, liquid biopsy development for neurological conditions, and multiplex imaging biomarkers. Collaborations between pharmaceutical companies and academic research centers will speed up biomarker translation from research to clinical use.





Reasons To Buy

Image



Scope

Image

Key Players

  • Thermo Fisher Scientific
  • Merck KGaA
  • Bio-Rad
  • Abcam
  • Qiagen
  • PerkinElmer
  • Myriad Genetics
  • Siemens Healthineers

Central Nervous System (CNS) Biomarker Market Report


  1. 1. Central Nervous System (CNS) Biomarker Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Central Nervous System (CNS) Biomarker Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Central Nervous System (CNS) Biomarker Market Research Report - Preface
    1. 2.1 Central Nervous System (CNS) Biomarker Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Biomarker Type:
      2. 2.1.2 By Application:
      3. 2.1.3 By End User:
      4. 2.1.4 By Region
  3. 3. Central Nervous System (CNS) Biomarker Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Biomarker Type:, By Application:, By End User:, By Country
    3. 3.3. Opportunities – By Biomarker Type:, By Application:, By End User:, By Country
    4. 3.4. Trends – By Biomarker Type:, By Application:, By End User:, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Central Nervous System (CNS) Biomarker Market Research Report – DROTs Impact Analysis
    1. 4. Central Nervous System (CNS) Biomarker Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Central Nervous System (CNS) Biomarker Market, By Biomarker Type:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Safety Biomarkers
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Efficacy Biomarkers
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Predictive Biomarkers
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Prognostic Biomarkers
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 5.5 Diagnostic Biomarkers
    22. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Central Nervous System (CNS) Biomarker Market, By Application:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Drug Discovery & Development
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Diagnostics
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Disease Risk Assessment
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Personalized Medicine
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 6.5 Clinical Trials Monitoring
    22. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Central Nervous System (CNS) Biomarker Market, By End User:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Pharmaceutical & Biotechnology Companies
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Academic & Research Institutes
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Hospitals & Clinical Labs
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 Contract Research Organizations (CROs)
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Central Nervous System (CNS) Biomarker Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Central Nervous System (CNS) Biomarker Market - Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Region, 2024 - 2031
  1. 9. North America Central Nervous System (CNS) Biomarker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Biomarker Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Safety Biomarkers
      2. 9.1.2 Efficacy Biomarkers
      3. 9.1.3 Predictive Biomarkers
      4. 9.1.4 Prognostic Biomarkers
      5. 9.1.5 Diagnostic Biomarkers
      9.2 By Application: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Drug Discovery & Development
      2. 9.2.2 Diagnostics
      3. 9.2.3 Disease Risk Assessment
      4. 9.2.4 Personalized Medicine
      5. 9.2.5 Clinical Trials Monitoring
      9.3 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Pharmaceutical & Biotechnology Companies
      2. 9.3.2 Academic & Research Institutes
      3. 9.3.3 Hospitals & Clinical Labs
      4. 9.3.4 Contract Research Organizations (CROs)
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
    2. 9.5 North America Central Nervous System (CNS) Biomarker Market – Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Central Nervous System (CNS) Biomarker Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Central Nervous System (CNS) Biomarker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Biomarker Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Safety Biomarkers
      2. 10.1.2 Efficacy Biomarkers
      3. 10.1.3 Predictive Biomarkers
      4. 10.1.4 Prognostic Biomarkers
      5. 10.1.5 Diagnostic Biomarkers
      10.2 By Application: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Drug Discovery & Development
      2. 10.2.2 Diagnostics
      3. 10.2.3 Disease Risk Assessment
      4. 10.2.4 Personalized Medicine
      5. 10.2.5 Clinical Trials Monitoring
      10.3 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Pharmaceutical & Biotechnology Companies
      2. 10.3.2 Academic & Research Institutes
      3. 10.3.3 Hospitals & Clinical Labs
      4. 10.3.4 Contract Research Organizations (CROs)
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
    2. 10.5 Europe Central Nervous System (CNS) Biomarker Market – Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Central Nervous System (CNS) Biomarker Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Central Nervous System (CNS) Biomarker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Biomarker Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Safety Biomarkers
      2. 11.1.2 Efficacy Biomarkers
      3. 11.1.3 Predictive Biomarkers
      4. 11.1.4 Prognostic Biomarkers
      5. 11.1.5 Diagnostic Biomarkers
      11.2 By Application: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Drug Discovery & Development
      2. 11.2.2 Diagnostics
      3. 11.2.3 Disease Risk Assessment
      4. 11.2.4 Personalized Medicine
      5. 11.2.5 Clinical Trials Monitoring
      11.3 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Pharmaceutical & Biotechnology Companies
      2. 11.3.2 Academic & Research Institutes
      3. 11.3.3 Hospitals & Clinical Labs
      4. 11.3.4 Contract Research Organizations (CROs)
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 ASEAN
    2. 11.5 Asia-Pacific Central Nervous System (CNS) Biomarker Market – Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Central Nervous System (CNS) Biomarker Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Central Nervous System (CNS) Biomarker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Biomarker Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Safety Biomarkers
      2. 12.1.2 Efficacy Biomarkers
      3. 12.1.3 Predictive Biomarkers
      4. 12.1.4 Prognostic Biomarkers
      5. 12.1.5 Diagnostic Biomarkers
      12.2 By Application: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Drug Discovery & Development
      2. 12.2.2 Diagnostics
      3. 12.2.3 Disease Risk Assessment
      4. 12.2.4 Personalized Medicine
      5. 12.2.5 Clinical Trials Monitoring
      12.3 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Pharmaceutical & Biotechnology Companies
      2. 12.3.2 Academic & Research Institutes
      3. 12.3.3 Hospitals & Clinical Labs
      4. 12.3.4 Contract Research Organizations (CROs)
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
    2. 12.5 Latin America Central Nervous System (CNS) Biomarker Market – Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Central Nervous System (CNS) Biomarker Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Central Nervous System (CNS) Biomarker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Biomarker Type: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Safety Biomarkers
      2. 13.1.2 Efficacy Biomarkers
      3. 13.1.3 Predictive Biomarkers
      4. 13.1.4 Prognostic Biomarkers
      5. 13.1.5 Diagnostic Biomarkers
      13.2 By Application: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Drug Discovery & Development
      2. 13.2.2 Diagnostics
      3. 13.2.3 Disease Risk Assessment
      4. 13.2.4 Personalized Medicine
      5. 13.2.5 Clinical Trials Monitoring
      13.3 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Pharmaceutical & Biotechnology Companies
      2. 13.3.2 Academic & Research Institutes
      3. 13.3.3 Hospitals & Clinical Labs
      4. 13.3.4 Contract Research Organizations (CROs)
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
    2. 13.5 Middle East and Africa Central Nervous System (CNS) Biomarker Market – Opportunity Analysis Index, By Biomarker Type:, By Application:, By End User:, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Central Nervous System (CNS) Biomarker Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 F. Hoffmann‑La Roche AG
      2. 14.2.2 Novartis AG
      3. 14.2.3 Siemens Healthineers
      4. 14.2.4 Thermo Fisher Scientific Inc
      5. 14.2.5 Abbott Laboratories
      6. 14.2.6 Merck KGaA
      7. 14.2.7 Eurofins Scientific
      8. 14.2.8 Charles River Laboratories International Inc
      9. 14.2.9 PerkinElmer Inc
      10. 14.2.10 Bio‑Rad Laboratories Inc
      11. 14.2.11 QIAGEN N.V.
      12. 14.2.12 Axon Neuroscience SE
      13. 14.2.13 Alector Inc
      14. 14.2.14 Oryzon Genomics S.A.
      15. 14.2.15 Banyan Biomarkers Inc.
  1. 15. Data Collection Method and Research Approach
  2. 16. Principal Presumptions and Acronyms